| Mepha Pharma AG - Buprenorphin-Mepha 8 mg, Sublingualtabletten | | 65188 | | 03 | | Buprenorphin-Mepha 8 mg | | Sublingualtabletten | | N07BC01 | | Buprenorphine | | 12.12.2014 | | |
| | Composition | | buprenorphinum 8 mg ut buprenorphini hydrochloridum 8.64 mg, magnesii stearas, crospovidonum, natrii citras anhydricus corresp. natrium 1.872 mg, povidonum K 29-32, acidum citricum, amylum pregelificatum, mannitolum, lactosum monohydricum 175.6 mg, E 110 0.76 mg, pro compresso. | | Packungsbestandteile | | Sublingual tablets | | | | | Active Agent | Dose |
|---|
| Buprenorphine | 8 mg |
| | BAG: Active Agent | Dose |
|---|
| Buprenorphine | 8 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Citric Acid | | | | Amylum Pregelificatum | | | | Crospovidonum | | | | E 110 | 0.76 mg | color. | | Lactose Monohydrate | 175.6 mg | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Citras Anhydricus | | | | Povidonum K | 29-32 | | | Pro Compresso | | |
| |
| |
|
